Amgen Industry Symposium

Managing multiple myeloma at first relapse: Emerging treatment paradigms

Sunday, May 9, 2021 – 12:20-13:30 CEST

Thomas Martin, MD
Clinical Professor of Medicine, Adult Leukemia and Bone Marrow Transplantation Program
Associate Director, Myeloma Program, UCSF
Co-Leader, Cancer Immunology & Immunotherapy Program,
Helen Diller Family Comprehensive Cancer Center

AGENDA:

12:20-13:10 Managing multiple myeloma at first relapse: Emerging treatment paradigms
Thomas Martin, MD
13:10-13:30 Q&A